{"name":"Cibus","slug":"cibus","ticker":"CBUS","exchange":"NASDAQ","domain":"cibus.com","description":"Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.","hq":"San Diego, CA","founded":0,"employees":"118","ceo":"Rory Riggs","sector":"Agricultural Biotechnology","stockPrice":1.43,"stockChange":-0.03,"stockChangePercent":-2.05,"marketCap":"$116M","metrics":{"revenue":3639000,"revenueGrowth":-12.8,"grossMargin":100,"rdSpend":44198000,"netIncome":-127085000,"cash":9923000,"dividendYield":0,"peRatio":-7.1,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-22","type":"regulatory","headline":"Cibus Receives EPA Registration for Novel Crop Protection Product","summary":"Cibus announced that it has received registration from the US Environmental Protection Agency (EPA) for its novel crop protection product, which is designed to control a range of pests and diseases in crops.","drugName":"","sentiment":"positive"},{"date":"2023-11-15","type":"earnings","headline":"Cibus Reports Strong Third Quarter 2023 Financial Results","summary":"Cibus reported strong financial results for the third quarter of 2023, with revenue growth and improved profitability.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxOVFBlY3NVdThPMmRsakd0TmhCSEktMHdDMWtfeFN0Tk5CUU5sdG92am5fY3VPVV9lVmxzUnVFcVA2cWdQSlNmNUlkTHluN2pabUlOSDhHTWhCV0dLMEZYQkZHNlJsYUdpby0ySC1qOU1EX3E4NHZNRjdFcjlqRWtkQTl3MW5GUjd3MUk5TktibUk3cFVjY1pGV2w4dmhtb1RaNmpGLUVB?oc=5","date":"2026-04-01","type":"pipeline","source":"Stock Titan","summary":"Cibus (CBUS) Sr VP withholds 1,763 shares for taxes, holds 101,879 - Stock Titan","headline":"Cibus (CBUS) Sr VP withholds 1,763 shares for taxes, holds 101,879","sentiment":"neutral"},{"date":"2026-03-27","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-03-17","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-03-17","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-01-30","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxOdTd4MFlHOF9sck1SUjFRaktKOVd2VHJITXJvUkhIS216WFJ0aTR3emEyNkVjTnBxTEZ6N0xvWWNpTFJUbGdRbzUwTjdjZF9RM2lmOXU2WndnOXZzaGoza2RxQUVfbnZ5OFdwdnRkNFhnZVB5amF6NTdYM0RfMnVjdExEdjgyQ19ZX0h6UDdjTFNlSEg1R3hkNW12ejFtOEZGOVFDeUhleGxkQ1I1YXd2YzdERnNydEN2NXp6NTZZN3Q?oc=5","date":"2026-01-29","type":"pipeline","source":"Stock Titan","summary":"Cibus board joins $20M share sale, backing rice weed trait R&D - Stock Titan","headline":"Cibus board joins $20M share sale, backing rice weed trait R&D","sentiment":"neutral"},{"date":"2026-01-28","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-04","type":"pipeline","source":"simplywall.st","summary":"Retail investors invested in Cibus, Inc. (NASDAQ:CBUS) up 11% last week, insiders too were rewarded - simplywall.st","headline":"Retail investors invested in Cibus, Inc. (NASDAQ:CBUS) up 11% last week, insiders too were rewarded","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiSEFVX3lxTE5kQ3ZMZVhhUVFQWUJsazJrUU96RGdyMHFSeExqSzF5Z1BqQnEwckw0TVktZEw4SU1tZ1loOVpvVktfUlQyampORQ?oc=5","date":"2025-05-12","type":"pipeline","source":"Intellectia AI","summary":"CBUS Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI","headline":"CBUS Stock: Price, Forecast, Financials & AI Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUEFVX3lxTE1YUS1EUnVUWlp5bG9XTjBYNl9OZzdzVm1qWnR5N2VpbWpROVM1eW85SGtNVUgwSDA0ZWlhcy1fdTVpcTNMMTBidjRfMW50Ujcx?oc=5","date":"2024-03-20","type":"pipeline","source":"CNN","summary":"symbol__ Stock Quote Price and Forecast - CNN","headline":"symbol__ Stock Quote Price and Forecast","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPWE9kMWVENkl6YlNmOWo3Z1lhNlBRUkNiWWRGQnZFaWVXNzJTMnNiRmEtczNyYkpjTWFwWEdiQnJzcmZLUFVZT0xvNUxJVDVhajRsQlFMOGlCYk1iQUJOTlhCRW5rZVVMTW9ZWHpvWGVTT19xVG5XeDlsMnMzMXViZ0hjWm95V2tiYmpGRlRxSWdmMXBCaXlr?oc=5","date":"2023-10-27","type":"pipeline","source":"Seeking Alpha","summary":"Cibus: A Pioneer In Gene Editing, The Future of Agriculture (NASDAQ:CBUS) - Seeking Alpha","headline":"Cibus: A Pioneer In Gene Editing, The Future of Agriculture (NASDAQ:CBUS)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE51aHZXN0xGRHdYRGJHeHlPSDQzaXlDVmtDUEVDYlJGSFozQ2FJWVJ5Tmp2RGhuU25qb2FRNUpFc2N3eEo5TXRoak5fUXFPQjFkM0xabWl4MWt3cGMz?oc=5","date":"2023-06-20","type":"pipeline","source":"Yahoo! Finance Canada","summary":"Cibus, Inc. (CBUS) Stock Major Holders - Yahoo! Finance Canada","headline":"Cibus, Inc. (CBUS) Stock Major Holders - Yahoo! Finance Canada","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTFBaOFMtaVdUUDRNVml4bFkxUWdIRmIxNTQ5SDhRY1RqZFJpQXl2UFpHcmpWWFNIUWtZY1BPcDlHWkt1MFNDZmpSYXllOU5PZFQ5aXlHanR0UU05Zw?oc=5","date":"2023-06-04","type":"pipeline","source":"MarketBeat","summary":"Cibus (CBUS) Stock Price, News & Analysis - MarketBeat","headline":"Cibus (CBUS) Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxPdlZxOC1HUloyeE52c2V0YVdUSUhlQjZSQmdLTnRvUkcyNWprcW9IdEhGQXpqdWpPT205cmRFVmoyWWJqTGFoV2k2RTlyN3dmOWxTMjRWMnNWWTludUx6Q21HWlN6amVhdTAzS1dwOEJBTmYteWZQNkdPUTkxbGFMQQ?oc=5","date":"2023-06-04","type":"pipeline","source":"MarketBeat","summary":"Top Cibus (CBUS) Competitors 2026 - MarketBeat","headline":"Top Cibus (CBUS) Competitors 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTE9BYzExa2ZHWm8wWFVoN3ZhSlNjVXpva3hxWHRHQWFoOTE0cU4wX3QwZU5SbEhqcXZ4emF1emk4dlhRMGhNQ2hBU1FNWThuVEFZNTJfalk0aFgyaDZqcFZ5dDVaOEtYUQ?oc=5","date":"2023-06-04","type":"earnings","source":"MarketBeat","summary":"Cibus (CBUS) Earnings Date and Reports 2026 - MarketBeat","headline":"Cibus (CBUS) Earnings Date and Reports 2026","sentiment":"positive"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Bayer","Monsanto","Syngenta"],"therapeuticFocus":["Crop protection","Crop improvement"],"financials":{"source":"sec_edgar+yahoo","revenue":3639000,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":3639000,"period":"2025-12-31"},{"value":4262000,"period":"2024-12-31"},{"value":4262000,"period":"2024-12-31"},{"value":1817000,"period":"2023-12-31"},{"value":1817000,"period":"2023-12-31"}],"grossProfit":3639000,"grossProfitHistory":[{"period":"2025-12-31","value":3639000},{"period":"2024-12-31","value":4262000},{"period":"2023-12-31","value":1817000},{"period":"2022-12-31","value":157000}],"rdSpend":44198000,"rdSpendHistory":[{"period":"2025-12-31","value":44198000},{"period":"2024-12-31","value":50429000},{"period":"2023-12-31","value":42367000},{"period":"2022-12-31","value":11553000}],"sgaSpend":26905000,"operatingIncome":-67464000,"operatingIncomeHistory":[{"period":"2025-12-31","value":-67464000},{"period":"2024-12-31","value":-76964000},{"period":"2023-12-31","value":-69464000},{"period":"2022-12-31","value":-22370000}],"netIncome":-127085000,"netIncomeHistory":[{"period":"2025-12-31","value":-127085000},{"period":"2024-12-31","value":-251388000},{"period":"2023-12-31","value":-267627000},{"period":"2022-12-31","value":-16891000}],"eps":-10.83,"epsHistory":[{"period":"2024-12-31","value":-10.83},{"period":"2023-12-31","value":-25.95},{"period":"2022-12-31","value":-18.5},{"period":"2021-12-31","value":-39}],"cash":9923000,"cashHistory":[{"period":"2025-12-31","value":9923000},{"period":"2024-12-31","value":14433000},{"period":"2023-12-31","value":32699000},{"period":"2022-12-31","value":3427000}],"totalAssets":305047000,"totalLiabilities":283218000,"totalDebt":33042000,"equity":21829000,"operatingCashflow":-50591000,"operatingCashflowHistory":[{"period":"2025-12-31","value":-50591000},{"period":"2024-12-31","value":-58043000},{"period":"2023-12-31","value":-46210000},{"period":"2022-12-31","value":-19364000}],"capex":-578000,"capexHistory":[{"period":"2025-12-31","value":-578000},{"period":"2024-12-31","value":-808000},{"period":"2023-12-31","value":-4321000},{"period":"2022-12-31","value":-1520000}],"freeCashflow":-51169000,"dividendsPaid":null,"buybacks":null,"employees":118,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":5129000,"ebit":-22536000,"ebitda":-21242000,"period":"2025-12-31","revenue":1057000,"epsBasic":-0.59,"netIncome":-31286000,"rdExpense":9387000,"epsDiluted":-0.59,"grossProfit":null,"operatingIncome":-13459000},{"sga":5269000,"ebit":-15279000,"ebitda":-13859000,"period":"2025-09-30","revenue":615000,"epsBasic":-0.44,"netIncome":-23541000,"rdExpense":10784000,"epsDiluted":-0.44,"grossProfit":null,"operatingIncome":-15438000},{"sga":6651000,"ebit":-17863000,"ebitda":-16288000,"period":"2025-06-30","revenue":933000,"epsBasic":-0.61,"netIncome":-25372000,"rdExpense":12228000,"epsDiluted":-0.61,"grossProfit":null,"operatingIncome":-17946000},{"sga":9856000,"ebit":-41013000,"ebitda":-39379000,"period":"2025-03-31","revenue":1034000,"epsBasic":-1.34,"netIncome":-46886000,"rdExpense":11799000,"epsDiluted":-1.34,"grossProfit":null,"operatingIncome":-20621000},{"sga":6803000,"ebit":-17561000,"ebitda":-15913000,"period":"2024-12-31","revenue":1212000,"epsBasic":-0.87,"netIncome":-23102000,"rdExpense":12433000,"epsDiluted":-0.87,"grossProfit":null,"operatingIncome":-18024000}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":1.43,"previousClose":1.46,"fiftyTwoWeekHigh":4.19,"fiftyTwoWeekLow":1.09,"fiftyTwoWeekRange":"1.09 - 4.191","fiftyDayAverage":2.12,"twoHundredDayAverage":1.8,"beta":1.66,"enterpriseValue":358722368,"forwardPE":-7.1,"priceToBook":3.56,"priceToSales":31.8,"enterpriseToRevenue":98.58,"enterpriseToEbitda":-5.83,"pegRatio":0,"ebitda":-61541000,"ebitdaMargin":0,"freeCashflow":-51790624,"operatingCashflow":-50591000,"totalDebt":267964992,"debtToEquity":1227.6,"currentRatio":0.72,"returnOnAssets":-12.9,"returnOnEquity":-221,"analystRating":"","recommendationKey":"none","numberOfAnalysts":3,"targetMeanPrice":14.67,"targetHighPrice":25,"targetLowPrice":3,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":0,"insiderHeldPercent":24.7,"institutionHeldPercent":21.9,"sharesOutstanding":76283095,"floatShares":51886712,"sharesShort":4416565,"shortRatio":6.86,"shortPercentOfFloat":5.8,"epsTrailing":-2.78,"epsForward":-0.2,"revenuePerShare":0.08,"bookValue":0.4,"officers":[{"age":62,"name":"Dr. Peter R. Beetham B.Sc., Ph.D.","title":"Co-Founder, Interim CEO, President, COO & Director"},{"age":56,"name":"Dr. Gregory F. Gocal Ph.D.","title":"Co-Founder, Chief Scientific Officer & Executive VP"},{"age":72,"name":"Mr. Rory Balfour Riggs M.B.A.","title":"Co-Founder & Director"},{"age":54,"name":"Mr. Jason  Stokes Esq., J.D.","title":"Chief Administrative Officer, General Counsel & Corporate Secretary"},{"age":53,"name":"Mr. Cornelis  Broos M.Sc.","title":"Chief Financial Officer"},{"age":null,"name":"Ms. Rosa Cheuk Kim J.D.","title":"Senior Vice President of Legal"},{"age":58,"name":"Dr. Noel  Sauer Ph.D.","title":"Senior Vice President of Research"}],"industry":"Biotechnology","irWebsite":"","website":"https://www.cibus.com","phone":"858 450 0008"}}